CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

Plymouth

(Photo by Cristina Arias/Cover/Getty Images)

Bosch Breaks Ground On Tech Center Expansion In Plymouth

Bosch says it will nearly double the facility’s size and bring up to 200 new jobs in the next three years.

CBS Detroit–08/25/2014

Esperion Therapeutics

Esperion Posts Big Loss, But Drug Test Results Promising

Esperion Therapeutics Inc., (Nasdaq: ESPR), the pharmaceutical company developing promising new cholesterol therapies, reported a big loss for 2013 — but continued promising clincal trial results.

WWJ Newsradio 950–03/07/2014

laser

Rofin-Sinar Buys Assets Of Oregon Laser Firm

Rofin-Sinar Technologies Inc., a Plymouth maker of industrial lasers, announced that it had an agreement to acquire the assets of Portland, Ore.-based FiLaser USA LLC.

WWJ Newsradio 950–02/28/2014

(credit: Sandra McNeil/WWJ)

Plymouth Garage Caves In Under Heavy Snow [VIDEO]

The weight of this season’s snow may be to blame for a roof collapse in Plymouth.

WWJ Newsradio 950–02/20/2014

Tech Earnings: Dow Corning, Rofin-Sinar

Both Midland-based Dow Corning Corp. and Rofin-Sinar Technologies Inc. of Plymouth reported earnings this week for the quarter ended Dec. 31.

WWJ Newsradio 950–02/05/2014

ProNAi

ProNAi Raises $12M Series C Financing To Expand Cancer Studies

The cancer drug developer ProNAi Therapeutics Inc. Monday announced the closing of a Series C preferred financing round of more than $12 million with existing and new investors.

WWJ Newsradio 950–01/13/2014

Esperion logo

Esperion Therapeutics Added To Nasdaq Biotech Index

Esperion Therapeutics Inc. (Nasdaq: ESPR) says its shares have been added to the Nasdaq Biotechnology Index effetive Dec. 23.

WWJ Newsradio 950–12/30/2013

Humanetics

Humanetics Bought By San Francisco Firm

Plymouth-based Humanetics Innovative Solutions Inc. and affiliated companies Wednesday announced their acquisition by Golden Gate Capital, a San Francisco private equity firm.

WWJ Newsradio 950–12/04/2013

Esperion Therapeutics

Esperion Therapeutics Presents Promising Test Results On Cholesterol Drug

The pharma startup Esperion Therapeutics Inc. Monday announced full results of a Phase 2 clincal study of its lead drug candidate, called ETC-1002. The drug is intended to reduce high cholesterol levels in patients with a history of intolerance to today’s cholesterol-lowering statin drugs.

WWJ Newsradio 950–11/18/2013

PHILIPINES-WEATHER-TYPHOON

Comcast Offers Free Calls To Philippines, Free Filipino Channel

In the devastating aftermath of Typhoon Haiyan, Comcast Corp. Wednesay announced that it is offering free calls to the Philippines to its 10.5 million Xfinity Voice residential customers.

WWJ Newsradio 950–11/13/2013

more

Follow

Get every new post delivered to your Inbox.

Join 1,911 other followers